Growth Metrics

Standard Biotools (LAB) Depreciation & Amortization (CF) (2016 - 2026)

Standard Biotools has reported Depreciation & Amortization (CF) over the past 16 years, most recently at $1.3 million for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) fell 58.89% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.3 million through Dec 2025, down 25.99% year-over-year, with the annual reading at $9.3 million for FY2025, 25.99% down from the prior year.
  • Depreciation & Amortization (CF) was $1.3 million for Q4 2025 at Standard Biotools, down from $1.5 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $6.0 million in Q2 2021 and troughed at $802000.0 in Q3 2022.
  • The 5-year median for Depreciation & Amortization (CF) is $1.3 million (2025), against an average of $2.0 million.
  • Year-over-year, Depreciation & Amortization (CF) surged 545.56% in 2021 and then plummeted 85.33% in 2022.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $2.7 million in 2021, then crashed by 70.15% to $819000.0 in 2022, then surged by 35.04% to $1.1 million in 2023, then surged by 183.91% to $3.1 million in 2024, then crashed by 58.89% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Depreciation & Amortization (CF) are $1.3 million (Q4 2025), $1.5 million (Q3 2025), and $3.2 million (Q2 2025).